keyword
https://read.qxmd.com/read/38652001/a-novel-crispr-cas12a-mediated-ratiometric-dual-signal-electrochemical-biosensor-for-ultrasensitive-and-reliable-detection-of-circulating-tumor-deoxyribonucleic-acid
#21
JOURNAL ARTICLE
Jiangbo Dong, Xinyao Li, Changjun Hou, Jingzhou Hou, Danqun Huo
Circulating tumor DNA (ctDNA) holds great promise as a noninvasive biomarker for cancer diagnosis, treatment, and prognosis. However, the accurate and specific quantification of low-abundance ctDNA in serum remains a significant challenge. This study introduced, for the first time, a novel exponential amplification reaction (EXPAR)-assisted CRISPR/Cas12a-mediated ratiometric dual-signal electrochemical biosensor for ultrasensitive and reliable detection of ctDNA. To implement the dual-signal strategy, a signal unit (ssDNA-MB@Fc/UiO-66-NH2 ) was prepared, consisting of methylene blue-modified ssDNA as the biogate to encapsulate ferrocene signal molecules within UiO-66-NH2 nanocarriers...
April 23, 2024: Analytical Chemistry
https://read.qxmd.com/read/38651937/molecular-classification-and-intratumoral-heterogeneity-of-gastric-adenocarcinoma
#22
REVIEW
Takeshi Kuwata
Gastric cancers frequently harbor striking histological complexity and diversity between lesions as well as within single lesions, known as inter- and intratumoral heterogeneity, respectively. The latest World Health Organization Classification of Tumors designated more than 30 histological subtypes for gastric epithelial tumors, assigning 12 subtypes for gastric adenocarcinoma (GAD). Meanwhile, recent advances in genome-wide analyses have provided molecular aspects to the histological classification of GAD, and consequently revealed different molecular traits underlying these histological subtypes...
April 23, 2024: Pathology International
https://read.qxmd.com/read/38651727/genomic-and-transcriptomic-landscape-of-ret-wild-type-medullary-thyroid-cancer-and-potential-use-of-mitogen-activated-protein-kinase-targeted-therapy
#23
JOURNAL ARTICLE
Sourat Darabi, Tolulope Adeyelu, Andrew Elliott, Ammar Sukari, Kurt Hodges, Farah Abdulla, Carlos E Zuazo, Trisha Wise-Draper, Thomas Wang, Michael J Demeure
BACKGROUND: About 75% of medullary thyroid cancers (MTCs) are sporadic with 45-70% being driven by a RET mutation. Selpercatinib is an approved treatment for RET-mutated (mutRET) MTC, however, treatments are needed for wild-type RET MTC (wtRET). Genomic alterations and transcriptomic signatures of wtRET MTC may reveal new therapeutic insights. METHODS: We did a retrospective analysis of MTC samples submitted for DNA/RNA sequencing and PD-L1 expression using IHC at a CLIA/CAP-certified lab...
April 23, 2024: Journal of the American College of Surgeons
https://read.qxmd.com/read/38651642/the-role-of-tumor-associated-macrophages-in-hepatocellular-carcinoma-from-bench-to-bedside-a-review
#24
REVIEW
Maciej Gryziak, Leszek Kraj, Rafał Stec
Hepatocellular carcinoma is one of the most common cancers worldwide. Despite progress in treatment, recurrence after radical treatment is common, and the prognosis remains poor for patients with advanced disease. Therefore, there is a need to identify prognostic and predictive factors for the response to therapy or more intensive surveillance or treatment. Because the tumor microenvironment plays a crucial role in the development of cancer and metastasis, it is a crucial need to understand processes that are involved in carcinogenesis...
April 23, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38651630/a-long-retention-cell-membrane-targeting-aiegen-for-boosting-tumor-theranostics
#25
JOURNAL ARTICLE
Xing Wang, Li Yang, Yuanhang Li, Xiaohan Wang, Zhengjian Qi
Designing and developing photosensitizers with cell membrane specificity is crucial for achieving effective multimodal therapy of tumors compared to other organelles. Here, we designed and screened a photosensitizer CM34 through donor/receptor regulation strategies, and it is able to achieve long-retention cell membrane targeting. It is not only an extremely excellent cell membrane targeted tumor theranostic agent, but also found to be a promising potential immune activator. Specifically, CM34 with a larger intramolecular twist angle is more likely to form larger aggregates in aqueous solutions, and the introduction of cyanide group also enhances its interaction with cell membranes, which were key factors hindering molecular penetration of the cell membrane and prolonging its residence time on the cell membrane, providing conditions for further membrane targeted photodynamic therapy...
April 23, 2024: Chemistry, An Asian Journal
https://read.qxmd.com/read/38651386/gallic-acid-loaded-hfzif-8-for-tumor-targeted-delivery-and-thermal-catalytic-therapy
#26
JOURNAL ARTICLE
Xing Yang, Chunsheng Li, Shuang Liu, Yunlong Li, Xinyu Zhang, Qiang Wang, Jin Ye, Yong Lu, Yujie Fu, Jiating Xu
"Transition" metal-coordinated plant polyphenols are a type of promising antitumor nanodrugs owing to their high biosafety and catalytic therapy potency; however, the major obstacle restricting their clinical application is their poor tumor accumulation. Herein, Fe-doped ZIF-8 was tailored using tannic acid (TA) into a hollow mesoporous nanocarrier for gallic acid (GA) loading. After hyaluronic acid (HA) modification, the developed nanosystem of HFZIF-8/GA@HA was used for the targeted delivery of Fe ions and GA, thereby intratumorally achieving the synthesis of an Fe-GA coordinated complex...
April 23, 2024: Nanoscale
https://read.qxmd.com/read/38651381/neuropilin-1-targeted-nanomedicine-for-spatiotemporal-tumor-suppression-through-photodynamic-vascular-damage-and-antiangiogenesis
#27
JOURNAL ARTICLE
Xin-Yu Li, Ni Yan, Ye-Yang Wu, Ren-Jiang Kong, Zi-Wen Qiu, Shu-Peng Liu, De-Hua Wu, Hong Cheng
Antiangiogenic therapy is an effective way to disrupt nutrient supply and starve tumors, but it is restricted by poor efficacy and negative feedback-induced tumor relapse. In this study, a neuropilin-1 (NRP-1)-targeted nanomedicine (designated as FPPT@Axi) is reported for spatiotemporal tumor suppression by combining photodynamic therapy (PDT) with antiangiogenesis. In brief, FPPT@Axi is prepared by utilizing an NRP-1-targeting chimeric peptide (Fmoc-K(PpIX)-PEG8 -TKPRR) to encapsulate the antiangiogenic drug Axitinib (Axi)...
April 23, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38651282/usp3-key-deubiquitylation-enzyme-in-human-diseases
#28
REVIEW
Hongyan Zhang, Wenjing Liu, Yingying Wu, Ceshi Chen
Ubiquitination and deubiquitylation are pivotal posttranslational modifications essential for regulating cellular protein homeostasis and are implicated in the development of human diseases. Ubiquitin-specific protease 3 (USP3), a member of the ubiquitin-specific protease family, serves as a key deubiquitylation enzyme, playing a critical role in diverse cellular processes including the DNA damage response, cell cycle regulation, carcinogenesis, tumor cell proliferation, migration, and invasion. Despite notable research efforts, our current understanding of the intricate and context-dependent regulatory networks governing USP3 remains incomplete...
April 23, 2024: Cancer Science
https://read.qxmd.com/read/38651235/custom-design-of-multi-stimuli-responsive-degradable-silica-nanoparticles-for-advanced-cancer-specific-chemotherapy
#29
REVIEW
Junjie Zhang, Jiani Zhou, Longguang Tang, Jiayi Ma, Ying Wang, Hui Yang, Xiaoxiao Wang, Wenpei Fan
Chemotherapy is crucial in oncology for combating malignant tumors but often encounters obatacles such as severe adverse effects, drug resistance, and biocompatibility issues. The advantages of degradable silica nanoparticles in tumor diagnosis and treatment lie in their ability to target drug delivery, minimizing toxicity to normal tissues while enhancing therapeutic efficacy. Moreover, their responsiveness to both endogenous and exogenous stimuli opens up new possibilities for integrating multiple treatment modalities...
April 23, 2024: Small
https://read.qxmd.com/read/38651187/pd-1-inhibition-with-retifanlimab-and-or-arginase-inhibition-with-incb001158-in-japanese-patients-with-solid-tumors-a-phase-i-study
#30
JOURNAL ARTICLE
Yasutoshi Kuboki, Takafumi Koyama, Nobuaki Matsubara, Yoichi Naito, Shunsuke Kondo, Kenichi Harano, Kan Yonemori, Kiyotaka Yoh, Yuan Gu, Tetsuya Mita, Xuejun Chen, Eiji Ueda, Noboru Yamamoto, Toshihiko Doi, Toshio Shimizu
BACKGROUND: Retifanlimab is a humanized monoclonal antibody targeting programmed death protein-1, and INCB001158 is an oral arginase inhibitor. This phase Ib study investigated retifanlimab, INCB001158, and their combination in Japanese patients with advanced solid tumors. METHODS: Patients received retifanlimab (500 mg every 4 weeks [Q4W] i.v.) or escalating doses of INCB001158 (75 or 100 mg twice daily [BID]) monotherapy in Part 1 and combination of retifanlimab (500 mg Q4W) and INCB001158 (100 mg BID) in Part 2...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38651178/survival-and-safety-analysis-of-covid-19-vaccine-in-chinese-patients-with-non-small-cell-lung-cancer
#31
JOURNAL ARTICLE
Wei Xu, Jing Zhao, Fang Luan, Zhizhao Zhang, Lei Liu, Hui Zhao, Bin Feng, Guobin Fu
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 disease (COVID-19) has caused a worldwide challenging and threatening pandemic. We aimed to assess the safety and efficacy of the COVID-19 vaccines in Non-Small Cell Lung Cancer (NSCLC) patients. METHODS: Patient self-reported adverse events related to vaccines were recorded by follow-up through a uniform questionnaire. Survival analysis was performed by Kaplan-Meier method. A multivariate analysis was performed by the Cox proportional hazard regression model to determine the effect of each variable on the survival of lung cancer patients...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38651150/sunitinib-for-adenocarcinoma-of-the-rete-testis-a-case-report
#32
Kezhen Li, Di Chen, Mingdong He, Jun Yu, Hua Mi
BACKGROUND: Adenocarcinoma of the rete testis (AORT) is an extremely rare and aggressive tumor with a poor prognosis. Its etiology and pathological characteristics have not been extensively studied, making accurate diagnosis and appropriate management challenging. AORT, an invasive testicular tumor with a mortality rate of 46%, treatment typically involves radical orchiectomy, retroperitoneal pelvic lymph node dissection (RPLND), adjuvant chemotherapy, and/or ongoing monitoring, but the response to conventional radiation and chemotherapy is limited...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651144/potential-role-of-the-eph-ephrin-system-in-colorectal-cancer-emerging-druggable-molecular-targets
#33
REVIEW
João Figueira Scarini, Moisés Willian Aparecido Gonçalves, Reydson Alcides de Lima-Souza, Luccas Lavareze, Talita de Carvalho Kimura, Ching-Chu Yang, Albina Altemani, Fernanda Viviane Mariano, Heloisa Prado Soares, Gary Chris Fillmore, Erika Said Abu Egal
The Eph/ephrin system regulates many developmental processes and adult tissue homeostasis. In colorectal cancer (CRC), it is involved in different processes including tumorigenesis, tumor angiogenesis, metastasis development, and cancer stem cell regeneration. However, conflicting data regarding Eph receptors in CRC, especially in its putative role as an oncogene or a suppressor gene, make the precise role of Eph-ephrin interaction confusing in CRC development. In this review, we provide an overview of the literature and highlight evidence that collaborates with these ambiguous roles of the Eph/ephrin system in CRC, as well as the molecular findings that represent promising therapeutic targets...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38651061/bioinformatics-analysis-and-experimental-verification-of-tigd1-in-non-small-cell-lung-cancer
#34
JOURNAL ARTICLE
Lingchun Xia, Zhuofan Yang, Mingming Xv, Guohui Wang, Yaxin Mao, Yihan Yang, Jian Tang
INTRODUCTION: Non-small cell lung cancer (NSCLC) is a prevalent respiratory system tumor. Triggered transposable element derivative 1 (TIGD1) exhibits significant overexpression in various tumor cells and tissues, suggesting its involvement in cancer progression. METHODS: Clinical data and gene expression profiles of lung adenocarcinoma were collected from TCGA, UCSC XENA, and GEO databases. Computational techniques and empirical studies were employed to analyze the role of TIGD1 in NSCLC...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38651004/cdpnet-a-radiomic-feature-learning-method-with-epigenetic-application-to-estimating-mgmt-promoter-methylation-status-in-glioblastoma
#35
JOURNAL ARTICLE
Jun Guo, Fanyang Yu, MacLean P Nasrallah, Christos Davatzikos
Radiomics has been widely recognized for its effectiveness in decoding tumor phenotypes through the extraction of quantitative imaging features. However, the robustness of radiomic methods to estimate clinically relevant biomarkers non-invasively remains largely untested. In this study, we propose Cascaded Data Processing Network (CDPNet), a radiomic feature learning method to predict tumor molecular status from medical images. We apply CDPNet to an epigenetic case, specifically targeting the estimation of O6-methylguanine-DNA-methyltransferase ( MGMT ) promoter methylation from Magnetic Resonance Imaging (MRI) scans of glioblastoma patients...
February 2024: Proceedings of SPIE
https://read.qxmd.com/read/38650929/ferroptosis-in-liver-cancer-a-key-role-of-post-translational-modifications
#36
REVIEW
Ying Xu, Zhiyao Xing, Ruaa Abdalla Ibrahim Suliman, Zichuan Liu, Fengyuan Tang
Ferroptosis is an emerging form of regulated cell death in an oxidative stress- and iron-dependent manner, primarily induced by the over-production of reactive oxygen species (ROS). Manipulation of ferroptosis has been considered a promising therapeutic approach to inhibit liver tumor growth. Nevertheless, the development of resistance to ferroptosis in liver cancer poses a significant challenge in cancer treatment. Post-translational modifications (PTMs) are crucial enzymatic catalytic reactions that covalently regulate protein conformation, stability and cellular activities...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650927/prognostic-value-of-cd8-t-cells-related-genes-and-exhaustion-regulation-of-notch-signaling-pathway-in-hepatocellular-carcinoma
#37
JOURNAL ARTICLE
Qing Pu, Lihua Yu, Xiaoli Liu, Huiwen Yan, Yuqing Xie, Xue Cai, Yuan Wu, Juan Du, Zhiyun Yang
Immunotherapy has emerged as the primary treatment modality for patients with advanced Hepatocellular carcinoma (HCC). However, its clinical efficacy remains limited, benefiting only a subset of patients, while most exhibit immune tolerance and face a grim prognosis. The infiltration of immune cells plays a pivotal role in tumor initiation and progression. In this study, we conducted an analysis of immune cell infiltration patterns in HCC patients and observed a substantial proportion of CD8+ T cells. Leveraging the weighted gene co-expression network analysis (WGCNA), we identified 235 genes associated with CD8+ T cell and constructed a risk prediction model...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650924/macrophages-plastic-participants-in-the-diagnosis-and-treatment-of-head-and-neck-squamous-cell-carcinoma
#38
REVIEW
Chen Lin, Yidian Chu, Ye Zheng, Shanshan Gu, Yanghao Hu, Jiali He, Zhisen Shen
Head and neck squamous cell carcinoma (HNSCC) rank among the most prevalent types of head and neck cancer globally. Unfortunately, a significant number of patients receive their diagnoses at advanced stages, limiting the effectiveness of available treatments. The tumor microenvironment (TME) is a pivotal player in HNSCC development, with macrophages holding a central role. Macrophages demonstrate diverse functions within the TME, both inhibiting and facilitating cancer progression. M1 macrophages are characterized by their phagocytic and immune activities, while M2 macrophages tend to promote inflammation and immunosuppression...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650920/second-line-treatment-of-pancreatic-adenocarcinoma-shedding-light-on-new-opportunities-and-key-talking-points-from-clinical-trials
#39
REVIEW
Robin Imperial, Osama Mosalem, Umair Majeed, Nguyen H Tran, Mitesh J Borad, Hani Babiker
Despite improvements in overall cancer mortality, deaths related to pancreatic cancer continue to rise. Following first-line treatment, second-line options are significantly limited. Classically, first-line treatment consisted of either gemcitabine or 5-fluorouracil based systemic chemotherapy. Upon progression of disease or recurrence, subsequent second-line treatment is still gemcitabine or 5-fluorouracil based chemotherapy, depending on what was used in the first line and the timing of progression or recurrence...
2024: Clinical and Experimental Gastroenterology
https://read.qxmd.com/read/38650823/insights-into-colorectal-carcinoma-a-comprehensive-review-of-microrna-expression-patterns
#40
REVIEW
Shweta Pandey, Akriti Jain, Sunita Vagha
Colorectal carcinoma (CRC) remains a significant contributor to cancer-related morbidity and mortality worldwide. MicroRNAs (miRNAs) have emerged as crucial regulators of gene expression and play critical roles in various biological processes, including carcinogenesis. This comprehensive review aims to elucidate the role of miRNAs in CRC by analyzing their expression patterns and functional implications. An extensive literature review identified dysregulated miRNAs associated with different stages of CRC progression, from initiation to metastasis...
March 2024: Curēus
keyword
keyword
117531
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.